Direkt zum Inhalt

Case details

Case Number: App_461803/2023

  • Patent number:
    EP4093384 - NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF,
    EP4175647 - ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS,
    EP4171736 - NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF

  • Proceeding type: Application

  • Action/Application: Inanspruchnahme der Ausnahmeregelung

  • Applicants:
    BUGNION S.P.A. Represented by CRISTINA BIGGI

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-01 14:51:27